Synergistic Interactions of MmpL3 Inhibitors With Antitubercular Compounds in Vitro

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.02399-16
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

In Vitro Interactions Between New Antitubercular Drug Candidates SQ109 and TMC207

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2010English

Synergistic Antitumor Effects of Novel HDAC Inhibitors and Paclitaxel in Vitro and in Vivo

PLoS ONE
Multidisciplinary
2011English

Potential Synergistic Effect of Phosphodiesterase Inhibitors With Chemotherapy in Lung Cancer

Journal of Cancer
Oncology
2017English

Combinatorial Treatment With mTOR Inhibitors and Streptozotocin Leads to Synergistic in Vitro and in Vivo Antitumor Effects in Insulinoma Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2017English

Transferrin Conjugates of Antitubercular Drug Isoniazid: Synthesis and in Vitro Efficacy

European Journal of Medicinal Chemistry
MedicineOrganic ChemistryDrug DiscoveryPharmacology
2019English

Inhibitors of Type II NADH:menaquinone Oxidoreductase Represent a Class of Antitubercular Drugs

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2005English

Studies on the Antitubercular Compounds. XV. Derivatives of 1, 4 -Dihydroxyphthalazine.

Nippon kagaku zassi
1958English

Antiplatelet Drug Interactions With Proton Pump Inhibitors

Expert Opinion on Drug Metabolism and Toxicology
MedicineToxicologyPharmacology
2013English

Synthesis, in Vitro Screening and Docking Studies of New Thiosemicarbazide Derivatives as Antitubercular Agents

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy